Caplight Directory>Companies>Augustine Therapeutics-preview>Augustinetx


Augustine Therapeutics

Augustine Therapeutics

Private
LeuvenN/Ahttps://www.augustinetx.com/

Last Round

Series A

Mar 24, 2025

Total Funding Raised

$108.08M

Momentum Score

50 /100

Company Overview

Augustine Therapeutics is a biotechnology company that develops therapeutic drugs designed to treat neuromuscular and neurodegenerative diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Augustine Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Augustine Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 24, 2025
Series AJun 26, 2024
SeedFeb 26, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

Gerhard Koenig

Chief Executive Officer

Executive Team

Augustine Therapeutics Investors

Notable investors and investment history

InvestorRounds
Gemma Frisius FundSeed, Series A
Asabys PartnersSeries A
Newton BiocapitalSeries A
V-Bio VenturesSeries A, Seed
Novo HoldingsSeries A
PMVSeed, Series A
VIBSeed, Series A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 406% MoM, reaching 3.1K.

  • Jan 2, 2026

    Monthly visitors grew 101% MoM, reaching 1.2K.

View all signals

Augustine Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Augustine Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Augustine Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeuven
Employee Range23
Year Founded2019
Last FundingMar 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.